TCIM
ELV icon

TIAA CREF Investment Management’s Elevance Health ELV Stock Holding History

TIAA CREF Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$221M Sell
771,053
-483,171
-39% -$140M 0.16% 129
2018
Q4 		$329M Sell
1,254,224
-25,582
-2% -$7.03M 0.26% 78
2018
Q3 		$351M Sell
1,279,806
-56,507
-4% -$14.7M 0.23% 95
2018
Q2 		$318M Sell
1,336,313
-259,655
-16% -$60.1M 0.21% 102
2018
Q1 		$351M Sell
1,595,968
-61,231
-4% -$14.4M 0.24% 96
2017
Q4 		$373M Sell
1,657,199
-28,215
-2% -$6.01M 0.25% 90
2017
Q3 		$320M Buy
1,685,414
+53,692
+3% +$10.2M 0.22% 102
2017
Q2 		$307M Sell
1,631,722
-31,004
-2% -$5.57M 0.22% 98
2017
Q1 		$275M Sell
1,662,726
-216,204
-12% -$34.4M 0.2% 103
2016
Q4 		$270M Buy
1,878,930
+191,381
+11% +$25.6M 0.2% 102
2016
Q3 		$211K Sell
1,687,549
-21,514
-1% -$2.78M 0.13% 151
2016
Q2 		$224M Sell
1,709,063
-204,901
-11% -$28M 0.17% 118
2016
Q1 		$266M Buy
1,913,964
+261,330
+16% +$34.9M 0.2% 104
2015
Q4 		$230M Sell
1,652,634
-288,173
-15% -$39.7M 0.17% 112
2015
Q3 		$272M Buy
1,940,807
+148,480
+8% +$22.3M 0.21% 100
2015
Q2 		$294M Sell
1,792,327
-173,185
-9% -$27.7M 0.21% 95
2015
Q1 		$303M Sell
1,965,512
-186,822
-9% -$26.6M 0.21% 98
2014
Q4 		$270M Sell
2,152,334
-60,663
-3% -$7.5M 0.19% 120
2014
Q3 		$265M Buy
2,212,997
+117,945
+6% +$13.5M 0.19% 120
2014
Q2 		$225M Buy
2,095,052
+161,555
+8% +$16.6M 0.16% 150
2014
Q1 		$192M Sell
1,933,497
-280,560
-13% -$25.4M 0.14% 162
2013
Q4 		$205M Buy
2,214,057
+58,648
+3% +$5.21M 0.15% 148
2013
Q3 		$180M Sell
2,155,409
-156,822
-7% -$13.4M 0.14% 163
2013
Q2 		$189M Buy
+2,312,231
New +$173M 0.15% 142

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TIAA CREF Investment Management's ELV Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Elevance Health (ELV) stake by 39% in Q1 2019, selling an estimated $140M and leaving 771,053 shares worth $221M. The position accounts for 0.16% of the portfolio, ranked #129.

TIAA CREF Investment Management first reported a position in ELV in Q2 2013 and has held it in 24 quarters since. The position peaked at $373M in Q4 2017. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • TIAA CREF Investment Management held 771,053 shares of Elevance Health worth $221M as of Q1 2019.
  • TIAA CREF Investment Management sold 483,171 Elevance Health shares in Q1 2019, an estimated $140M.
  • Elevance Health made up 0.16% of TIAA CREF Investment Management's portfolio in Q1 2019, its #129 holding.
  • TIAA CREF Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Elevance Health position peaked at $373M in Q4 2017.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.